title: Nicotine withdrawal in smokers with current depressive disorders undergoing intensive smoking cessation treatment.
abstract: The authors investigated withdrawal in smokers with current threshold and subthreshold depressive disorders (N = 21) who were participating in a pilot study of intensive counseling interventions for smoking cessation. The majority of participants (67%) were taking antidepressants when they entered the trial. Withdrawal symptoms were compared in prolonged abstainers versus nonabstainers across a 12-week treatment period and at the 3-month follow-up assessment visit. Prolonged abstinence was associated with an increase in positive affect and a decrease in depressive symptoms and craving over time. Nonabstinence was associated with little overall change in these variables from treatment onset to the 3-month follow-up. At the 3-month follow-up, 44% of prolonged abstainers were in complete remission of their baseline depressive disorders, compared with 0% remission among nonabstainers. Findings suggest that within the context of an intensive smoking cessation intervention, some smokers with current depressive disorders may experience significant improvement in affective and craving symptoms. Findings also suggest that abstinence may be associated with improvement in affect.
authors.affiliation: Department of Behavioral Science, University of Texas M. D. Anderson Cancer Center, Houston 77230-1439, USA. jablaloc@mdanderosn.org
authors.forename: Janice A
authors.initials: JA
authors.lastname: Blalock
authors.forename: Jason D
authors.initials: JD
authors.lastname: Robinson
authors.forename: David W
authors.initials: DW
authors.lastname: Wetter
authors.forename: Lisa S
authors.initials: LS
authors.lastname: Schreindorfer
authors.forename: Paul M
authors.initials: PM
authors.lastname: Cinciripini
mesh_terms: D000328:Adult; D003376:Counseling; D003866:Depressive Disorder / Q000453:epidemiology*; D039721:Diagnostic and Statistical Manual of Mental Disorders; D007174:Disruptive, Impulse Control, and Conduct Disorders / Q000453:epidemiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009538:Nicotine / Q000009:adverse effects*; D016540:Smoking Cessation / Q000379:methods* / Q000706:statistics & numerical data*; D000074606:Smoking Prevention; D013375:Substance Withdrawal Syndrome / Q000453:epidemiology* / Q000209:etiology*
chemical_list: D009538:Nicotine